Oncology One’s Head of Drug Discovery, Dr Richard Foitzik, is heading to Perth to participate in AusBiotech’s upcoming events, the annual AusBiotech Conference (26-28 Oct 2022) and AusBioinvest22 (27 Oct 2022).
AusBiotech 2022 will address issues essential to growing commercial opportunities for the local health and medical life sciences industry, including regenerative medicine, gene therapies, biotech investing, precision medicine and clinical trials.
Dr Foitzik has over 14 years’ industry experience in medicinal chemistry and management, and is an excellent ambassador for Oncology One in this forum.
